BIANCO, Andrea
 Distribuzione geografica
Continente #
EU - Europa 12.890
NA - Nord America 6.975
AS - Asia 5.968
SA - Sud America 945
Continente sconosciuto - Info sul continente non disponibili 467
AF - Africa 70
OC - Oceania 12
Totale 27.327
Nazione #
RU - Federazione Russa 8.576
US - Stati Uniti d'America 6.850
SG - Singapore 1.950
IE - Irlanda 1.349
CN - Cina 1.162
HK - Hong Kong 1.151
IT - Italia 902
VN - Vietnam 898
BR - Brasile 786
GB - Regno Unito 489
UA - Ucraina 458
DE - Germania 432
KR - Corea 298
GR - Grecia 157
FI - Finlandia 148
IN - India 119
FR - Francia 109
TR - Turchia 80
SE - Svezia 77
JP - Giappone 74
AR - Argentina 67
CA - Canada 48
BD - Bangladesh 46
MX - Messico 41
AT - Austria 40
BE - Belgio 36
EC - Ecuador 29
NL - Olanda 29
IQ - Iraq 25
ID - Indonesia 23
UZ - Uzbekistan 20
CH - Svizzera 17
PY - Paraguay 16
ZA - Sudafrica 16
ES - Italia 14
PL - Polonia 14
CL - Cile 13
MA - Marocco 13
IL - Israele 12
PH - Filippine 12
VE - Venezuela 12
AU - Australia 11
CO - Colombia 11
PK - Pakistan 11
AL - Albania 9
BJ - Benin 9
JM - Giamaica 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
PT - Portogallo 8
KE - Kenya 7
TW - Taiwan 7
AZ - Azerbaigian 6
EU - Europa 6
IR - Iran 6
JO - Giordania 6
NP - Nepal 6
TN - Tunisia 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
KZ - Kazakistan 5
MK - Macedonia 5
MY - Malesia 5
PE - Perù 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
LT - Lituania 4
GE - Georgia 3
HN - Honduras 3
KG - Kirghizistan 3
OM - Oman 3
PA - Panama 3
PS - Palestinian Territory 3
BG - Bulgaria 2
BH - Bahrain 2
ET - Etiopia 2
GT - Guatemala 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MU - Mauritius 2
QA - Qatar 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
KW - Kuwait 1
Totale 26.856
Città #
Moscow 3.042
Dublin 1.348
Hong Kong 1.122
Santa Clara 984
San Jose 917
Jacksonville 811
Chandler 762
Singapore 756
Ashburn 321
Seoul 293
Ho Chi Minh City 263
Beijing 251
Hanoi 213
The Dalles 190
Princeton 188
Hefei 170
Roxbury 163
Dallas 151
Naples 139
Medford 124
Bremen 123
Los Angeles 116
Munich 81
Nuremberg 81
Caserta 80
New York 78
Bengaluru 71
Cambridge 68
Da Nang 66
Wilmington 65
Des Moines 64
Ann Arbor 62
São Paulo 62
Boardman 61
Helsinki 53
Council Bluffs 50
Haiphong 50
Brussels 36
Rome 34
San Mateo 33
Woodbridge 33
Aversa 31
Seattle 31
Frankfurt am Main 30
Milan 28
Orem 28
Rio de Janeiro 27
Napoli 25
Atlanta 24
Tokyo 20
Belo Horizonte 19
Hải Dương 19
Orta di Atella 19
Shanghai 19
Tashkent 19
Dong Ket 18
Guangzhou 18
Jinan 18
Miami 18
Amsterdam 17
Memphis 17
Chennai 16
Chicago 16
Norwalk 16
Vienna 16
Mountain View 15
Brasília 14
Bắc Ninh 14
Columbus 14
San Giuseppe Vesuviano 14
Thái Bình 14
Curitiba 13
Mexico City 13
Nanjing 13
Biên Hòa 12
Bến Tre 12
Ercolano 12
Guayaquil 12
Montreal 12
San Francisco 12
Baghdad 11
Houston 11
Kunming 11
New Delhi 11
Ninh Bình 11
Tianjin 11
Toronto 11
Warsaw 11
Can Tho 10
Guarulhos 10
Jakarta 10
Porto Alegre 10
Thái Nguyên 10
Turku 10
Arzano 9
Istanbul 9
Manchester 9
Shenzhen 9
Boston 8
Como 8
Totale 14.480
Nome #
" Gemcitabine + Vinorelbine (GV) Vs Gemcitabine + Paclitaxel (GT) Vs Gemcitabine (G) Vs Paclitaxel (P) in elderly NSCLC patients". 233
Adiponectin down-regulates CREB and inhibits proliferation of A549 lung cancer cells 212
Anticoagulant treatment in COVID-19: a narrative review 210
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 206
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 201
Adiponectin affects lung epithelial A549 cell viability counteracting TNFa and IL-1ß toxicity through AdipoR1 188
Comorbidities in COPD: Current and Future Treatment Challenges 186
Adiponectin in asthma: Implications for phenotyping 183
Adiponectin: An attractive marker for metabolic disorders in chronic obstructive pulmonary disease (COPD) 180
Adiponectin is Associated with Neutrophils to Lymphocyte Ratio in Patients with Chronic Obstructive Pulmonary Disease 180
Adiponectin is involved in the control of human lung epithelial A549 cell viability 179
Evolving concepts in COPDand lung cancer: a narrative review 177
Adiponectin Increase in Patients Affected by Chronic Obstructive Pulmonary Disease with Overlap of Bronchiectasis 175
T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis 174
Integrated therapeutic approach to giant solitary fibrous tumor of the pleura: Report of a case and review of the literature 173
Adiponectin, Leptin, and Resistin Are Dysregulated in Patients Infected by SARS-CoV-2 171
Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease 170
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 170
Descending necrotizing mediastinitis in the elderly patients 166
Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold! 162
Adiponectin and leptin exert antagonizing effects on huvec tube formation and migration modulating the expression of cxcl1, vegf, mmp‐2 and mmp‐9 162
Aspetti anatomo clinici delle malattie respiratorie 161
Adiponectin as Link Factor between Adipose Tissue and Cancer 161
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis 160
Adiponectin and its isoforms are overexpressed in COPD patients 158
Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? 157
Asma Bronchiale (recenti acquisizioni sperimentali e contributi personali) 156
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 154
Effects of Different Corticosteroid Doses in Elderly Unvaccinated Patients with Severe to Critical COVID-19 154
Clinical characteristics, exercise capacity and pulmonary function in post-covid-19 competitive athletes 153
Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC 153
Effectiveness of home-based preoperative pulmonary rehabilitation in COPD patients undergoing lung cancer resection 153
Malattie dell'apparato respiratorio 152
Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist’s Key Role 151
A chest wall problem. 151
Cardiovascular system in COVID-19: Simply a viewer or a leading actor? 151
Exposure to Submicron Particles (PM1.0) from Diesel Exhaust and Pollen Allergens of Human Lung Epithelial Cells Induces Morphological Changes of Mitochondria Tonifilaments and Rough Endoplasmic Reticulum 150
EXPLORING THE ROLE OF KREBS VON DEN LUNGEN-6 (KL-6) IN SEVERE TO CRITICAL COVID-19: A SINGLE INSTITUTION EXPERIENCE 148
Exploring the Role of Krebs von den Lungen-6 in Severe to Critical COVID-19 Patients 147
Sirtuins and Cellular Senescence in Patients with Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Disorders 146
RFA of primary and metastatic lung tumors: long-term results 146
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report 145
A biological model to explain the association between human rhinovirus respiratory infections and bronchial asthma 144
B-flow twinkling sign in preoperative evaluation of cervical lymph nodes in patients with papillary thyroid carcinoma. 143
Spirometry in elderly laryngectomized patients: A feasibility study 143
Idiopathic pulmonary fibrosis and lung cancer: targeting the complexity of the pharmacological interconnection 142
Which impact for proton pump inhibitors in SARS-CoV-2 pneumonia 142
Cardiovascular prosthetic surgery: an analysis of cellular and molecular patterns underlying valve implantation failure. 140
Effects of diesel exhaust particles on human lung epithelial cells: an in vitro study 140
Benefits of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A CASE REPORT 140
Benefi ts of Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis 139
Lung and Nodal Involvement in Nontuberculous Mycobacterial Disease: PET/CT Role 138
Morphology changes in human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM 1.0) and pollen allergens 134
Routine invasive mediastinal staging of lung cancer in elderly patients without lymph adenopathy on pet-ct scan: Is an appropriate choice? 134
The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549 cells and oxidative stress involvement 134
Food, nutrition, physical activity and microbiota: Which impact on lung cancer? 134
Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt? 133
Ruolo dei fattori di crescita nella induzione della proliferazione fibroblastica nella patogenesi della fibrosi polmonare idiopatica 133
Effects of a high-intensity pulmonary rehabilitation program on the minute ventilation/carbon dioxide output slope during exercise in a cohort of patients with COPD undergoing lung resection for non-small cell lung cancer 133
Lung Microbiome as a Treatable Trait in Chronic Respiratory Disorders 132
I Farmaci Antiangiogenetici nel Trattamento del Tumore del Polmone 132
Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma 131
Altered peptide ligands change T cell repertoire expression in ParJ 1 specific cell lines 131
Non-small cell lung cancer presenting as "psoas muscle syndrome": A case report 129
Protective effects of nedocromil sodium on cellular and biohumoral components present in the bronchial alveolar lavage fluid and in peripheral blood in atopic asthmatics 128
Effetto antinfiammatorio del sodio nedocromile in pazienti asmatici atopici 127
Potential role of SIRT-1 and SIRT-3 as biomarkers for the diagnosis and prognosis of idiopathic pulmonary fibrosis 126
Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study. 126
BARD1: An independent predictor of survival in non-small cell lung cancer 126
Interferon-gamma downregulates the rhinovirus induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells 126
Differentially expressed and activated proteins associated with non small cell lung cancer tissues 125
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: Focus on sirtuins 124
New insight into adiponectin role in obesity and obesity-related diseases 123
Raw Bioelectrical Impedance Analysis Variables Are Independent Predictors of Early All-Cause Mortality in Patients With COPD 123
COPD and metabolic disorders: role of adiponectin 122
Disturbi neuropsicologici correlate alla BPCO 122
Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment 121
Case report: Selpercatinib in the treatment of RET fusion-positive advanced lung adenocarcinoma: a challenging clinical case 119
Frailty in Patients With Lung Cancer: A Systematic Review and Meta-Analysis 118
Endoscopic treatment of endobronchial carcinoid: technical considerations and experience in interventional pulmonology 118
Ketoprofen Lysine Salt Versus Corticosteroids in Early Outpatient Management of Mild and Moderate COVID-19: A Retrospective Study 118
Fractional exhaled nitric oxide-measuring devices: Technology update 118
Targeting Progression in Pulmonary Fibrosis: An Overview of Underlying Mechanisms, Molecular Biomarkers, and Therapeutic Intervention 117
Anti-inflammatory effects of adiponectin in A549 cells exposed to TNF alpha and IL-1 beta 117
Somatostatin-Dependent Regulation of Alveolar Macrophages Activation and Cytokine Production 117
Inflammatory effects on human lung epithelial cells after exposure to diesel exhaust micron sub particles (PM₁.₀) and pollen allergens. 116
IFNY TRIGGERS APOPTOSIS IN VITRO M.T. ACTIVATED ALVEOLAR MACROPHAGES 116
The burden of obesity in asthma and COPD: Role of adiponectin 116
CORRELATION BETWEEN CHEMICAL MEDIATORS AND HAEMORHEOLOGICAL - COAGULATIVE FACTORS IN THE PATHOGENESIS OF CHRONIC RESPIRATORY FAIL¬URE CAUSED BY INTERSTITIAL LUNG DISEASES (F.I.D) 115
Genomic Profiling for Predictive Treatment Strategies in Fibrotic Interstitial Lung Disease 114
High-Flow Nasal Cannula System in Respiratory Failure Associated with Interstitial Lung Diseases: A Systematic Review and Narrative Synthesis 114
La chemioterapia sequenziale nel trattamento del cancro del polmone non a piccole cellule (NSCLC) in operabile 114
Distinct BARD1 isoforms expressed in lung cancer potential targets for treatment 114
Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study 114
Mechanisms and Clinical Implications of Endothelial Dysfunction in Arterial Hypertension 113
Pharmacological Treatment of Interstitial Lung Diseases: A Novel Landscape for Inhaled Agents 113
Exploring the role of serum adiponectin and its holigomerization in fibrotic interstitial lung diseases: results from a cross-sectional study 112
Anti-inflammatory effect of sodium nedocromil in atopic asthmatic patients|EFFETTO ANTIINFIAMMATORIO DEL SODIO NEDOCROMILE IN PAZIENTI ASMATICI ATOPICI 112
Regimi di chemioterapia senza derivati del platino in pazienti con neoplasia polmonare non a piccole cellule (NSCLC) avanzata/metastatica (stadio IIIB/IV): efficacia dell’associazione Gemcitabina, Ifosamide, Paclitaxel (GIT). 112
Exploring the Network between Adipocytokines and Inflammatory Response in SARS-CoV-2 Infection: A Scoping Review 112
Totale 14.334
Categoria #
all - tutte 95.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.078 0 16 10 14 380 14 25 29 60 50 79 401
2022/20232.778 233 52 19 251 320 245 46 179 1.293 29 57 54
2023/20241.132 91 36 61 86 365 67 19 23 16 33 154 181
2024/20254.235 27 83 32 105 626 591 644 343 544 622 392 226
2025/202614.824 517 608 759 675 1.174 7.872 1.145 765 674 284 223 128
2026/2027388 111 277 0 0 0 0 0 0 0 0 0 0
Totale 27.327